Professor Jurgen Knoblich, a molecular biologist at the Institute of Molecular Biotechnology of the Austrian Academy of Sciences in Vienna is confident that the way to cost effectively test drugs for incurable neurological conditions is to use human brain tissue.To date most new drugs are initially tested on animal models and although the animals are specifically bred to show some of the characteristics of a particular condition or disorder, this can never totally mimic the disorder in the human being.  So although drug trials may be shown to be effective in minimising the symptoms of a particular condition in animals, this success may not in turn be transferred to the human situation.In his lab Professor Knoblich has developed a technique that creates brain tissue which shares the same DNA and disease-causing mutations as the patient. By growing brain tissue samples that have the same DNA mutations as people with diseases such as Alzheimer’s or epilepsy, researchers can test the impact of treatments on specific conditions. To read more about the research, just click here